SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Westert GP, Satariano WA, Schellevis FG, Van Den Bos GA. Patterns of comorbidity and the use of health services in the Dutch population. Eur J Public Health 2001; 11: 36572
  • 2
    Janssen-Heijnen ML, Houterman S, Lemmens VE et al. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55: 23140
  • 3
    Van De Poll-Franse LV, Houterman S, Janssen-Heijnen ML et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007; 120: 198692
  • 4
    Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 2004; 47: 10718
  • 5
    Saito I, Inami F, Ikebe T et al. Impact of diabetes on health-related quality of life in a population study in Japan. Diabetes Res Clin Pract 2006; 73: 517
  • 6
    Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol 2003; 169: 165361
  • 7
    Clark JA, Inui TS, Silliman RA et al. Patients’ perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 2003; 21: 377784
  • 8
    Wei JT, Dunn RL, Sandler HM et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002; 20: 55766
  • 9
    Potosky AL, Legler J, Albertsen PC et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000; 92: 158292
  • 10
    Miller DC, Sanda MG, Dunn RL et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005; 23: 277280
  • 11
    Hamilton AS, Stanford JL, Gilliland FD et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001; 19: 251726
  • 12
    Rijken M, Van Kerkhof M, Dekker J, Schellevis FG. Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning. Qual Life Res 2005; 14: 4555
  • 13
    Latini DM, Chan JM, Cowan JE et al. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology 2006; 68: 12427
  • 14
    Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 1999; 43: 4759
  • 15
    Penson DF, Latini DM, Lubeck DP et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003; 26: 10939
  • 16
    Korfage IJ, Essink-Bot ML, Borsboom GJ et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005; 116: 2916
  • 17
    Mols F, Van De Poll-Franse LV, Vingerhoets AJ et al. Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer 2006; 107: 218696
  • 18
    Janssen-Heijnen MLG, Louwman WJ, Van De Poll-Franse LV, Coebergh JWW. Results of 50 Years Cancer Registry in the South of the Netherlands: 1955–2004 Eindhoven: Eindhoven Cancer Registry, 2005 (in Dutch)
  • 19
    UICC. TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 4th edn. 2nd Revision. Berlin: SpringerVerlag, 1992: 1414
  • 20
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 37383
  • 21
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383
  • 22
    Ware JE Jr, Gandek B, Kosinski M et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 116770
  • 23
    Aaronson NK, Muller M, Cohen PD et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 105568
  • 24
    Ware JE Jr. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Centre, 1993
  • 25
    Norman GR, Sridhar FG, Guyatt GH, Walter SD. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001; 39: 103947
  • 26
    Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 58292
  • 27
    Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000; 56: 899905
  • 28
    Korfage IJ, Essink-Bot ML, Madalinska JB et al. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual Life Res 2003; 12: 45964
  • 29
    Dekker JM, Van Der Kraan M, Nijpels G et al. [Estimate of the number of new patients with type 2 diabetes mellitus in the Netherlands: at least 65 000 per year in the age group of 50 years and above]. Ned Tijdschr Geneeskd 2003; 147: 141923
  • 30
    Ko GT, Chan JC, Yeung VT et al. A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese. Eur J Epidemiol 2001; 17: 28995
  • 31
    Hu JC, Elkin EP, Pasta DJ et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004; 171: 7037
  • 32
    Wensing M, Vingerhoets E, Grol R. Functional status, health problems, age and comorbidity in primary care patients. Qual Life Res 2001; 10: 1418
  • 33
    Thommasen HV, Zhang W. Impact of chronic disease on quality of life in the Bella Coola Valley. Rural Remote Health 2006; 6: 528
  • 34
    Penson DF, Wessells H. Erectile dysfunction in diabetic patients. Diabetes Spectrum 2004; 17: 22530
  • 35
    Incrocci L. Sexual function after external-beam radiotherapy for prostate cancer: what do we know? Crit Rev Oncol Hematol 2006; 57: 16573
  • 36
    Potosky AL, Davis WW, Hoffman RM et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004; 96: 135867
  • 37
    Potosky AL, Reeve BB, Clegg LX et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 2002; 94: 4307